Global Digital Therapeutics Market Size

1. Global Digital Therapeutics Market Size, Share, Growth Analysis, By Application, By End-User, By Product, By Distribution Chanel - Industry Forecast 2023-2030 Global Digital Therapeutics Market size was valued at USD 968.6 million in 2021 and is poised to grow from USD 1035.6 million in 2022 to USD 1805.6 million by 2030, growing at a CAGR of 7.2% in the forecast period (2023-2030). Digital therapeutics is a branch of digital health that integrates innovative technologies, services, and products for healthcare and wellness. Digital therapies are used alone or in conjunction with medical devices to optimize treatments and medications based on patient care and health outcomes. To adopt personalized solutions, digital therapeutics use internet infrastructure, apps on mobile devices,machine learning big data, and artificial intelligence. Various apps that provide healthcare benefits to patients are developing rapidly. Digital medicines are changing the design of medical care and drug delivery systems with evidence-based advances and tolerable outcomes. It helps provide direct clinical treatment or therapy to patients using logical reporting, medical test programming used to treat patients, their administration, and medical testing used to anticipate chronic diseases or problems. Its products follow the same concepts and rules as traditional restorative products and medications. Digital therapy should adhere to several fundamental principles, for example, product safety, patient-centeredness, safety, quality, and developing the impact of clinical trials on that product. With the increasing acceptance of smartphones and tablets for the delivery of medical services globally, the demand for computerized utility products is increasing. Unexpectedly, emerging nations lack access to computerized treatment frameworks and mindfulness practices. This provides an

2. opportunity to tap into underdeveloped business sectors in developing countries and acquire significant benefits in the digital therapeutics market. Analysis by Application In 2021, the diabetic application segment accounted for more than 28.5% of the global revenue. The increasing prevalence of diabetes and other chronic conditions is one factor contributing to the category growth. Digital therapeutics can help healthcare doctors monitor patients' lives and tailor treatment plans based on their unique therapeutic needs. According to the CDC, nearly 34.2 million individuals will have diabetes in 2020, with the United States accounting for 10.5% of this number. Owing to the increasing obese population of the world, the obesity application segment accounted for the second-largest share in 2021. Digital therapies offer cost-effective options for the treatment of numerous chronic diseases, which will drive the market in the near future. Analysis by End User In 2021, the patient end-user category accounted for more than 33.0% of global revenue. This growth was mainly due to the adoption of digital therapeutic solutions by patients. Patients are the primary users of therapeutic healthcare applications and programs. As the number of individuals suffering from chronic diseases increases, the need for digital therapies is increasing. View more info:https://www.skyquestt.com/report/digital-therapeutics- market Top Player’s Company Profiles •Akili Interactive •Omada Health •Livongo Health •WellDoc •2Morrow Inc. •Canary Health

3. About us: SkyQuest Technology is leading growth consulting firm providing market intelligence, commercialization and technology services. It has 450+ happyclients globally. Address: 1 Apache Way, Westford, Massachusetts 01886 Phone: USA (+1) 617-230-0741 Email: sales@skyquestt.com linkedin Twitter Facebook